APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

C1 Esterase Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global C1 Esterase Inhibitors Market Outlook and Growth Opportunities 2026

Report ID 173973510429 December 2025196 pages

Choose your research edition.

Industry ResearchC1 Esterase Inhibitors Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal C1 Esterase Inhibitors Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal C1 Esterase Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C1 Esterase Inhibitors Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal C1 Esterase Inhibitors Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global C1 Esterase Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for C1 Esterase Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for C1 Esterase Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C1 Esterase Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the C1 Esterase Inhibitors market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the C1 Esterase Inhibitors market include Takeda, Pharming Healthcare and CSL Behring, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global C1 Esterase Inhibitors market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of C1 Esterase Inhibitors and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents C1 Esterase Inhibitors sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the C1 Esterase Inhibitors market size, projected growth trends, production technologies, key applications, and end-use industries.

C1 Esterase Inhibitors Segment by Company

Takeda

Pharming Healthcare

CSL Behring

C1 Esterase Inhibitors Segment by Type

Recombinant C1-INH

Plasma-derived C1-INH

C1 Esterase Inhibitors Segment by Application

Hospital and Clinic

Pharmacy

Other

C1 Esterase Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global C1 Esterase Inhibitors status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions C1 Esterase Inhibitors market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify C1 Esterase Inhibitors significant trends, drivers, influence factors in global and regions.

6. To analyze C1 Esterase Inhibitors competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C1 Esterase Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C1 Esterase Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C1 Esterase Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the C1 Esterase Inhibitors market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global C1 Esterase Inhibitors industry.

Chapter 3: Detailed analysis of C1 Esterase Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of C1 Esterase Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of C1 Esterase Inhibitors in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. C1 Esterase Inhibitors Industry Trends Table 2. C1 Esterase Inhibitors Industry Drivers Table 3. C1 Esterase Inhibitors Industry Opportunities and Challenges Table 4. C1 Esterase Inhibitors Industry Restraints Table 5. Global C1 Esterase Inhibitors Revenue by Company (US$ Million) & (2021-2026) Table 6. Global C1 Esterase Inhibitors Revenue Share by Company (2021-2026) Table 7. Global C1 Esterase Inhibitors Sales Volume by Company (K Units) & (2021-2026) Table 8. Global C1 Esterase Inhibitors Sales Volume Share by Company (2021-2026) Table 9. Global C1 Esterase Inhibitors Average Price (US$/Unit) of Company (2021-2026) Table 10. Global C1 Esterase Inhibitors Company Ranking, (2024-2026) & (USD Million) Table 11. Global C1 Esterase Inhibitors Key Company Manufacturing Base & Headquarters Table 12. Global C1 Esterase Inhibitors Company, Product Type & Application Table 13. Global C1 Esterase Inhibitors Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global C1 Esterase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Recombinant C1-INH Table 18. Significant Companies of Plasma-derived C1-INH Table 19. Global C1 Esterase Inhibitors Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global C1 Esterase Inhibitors Sales Volume by Type (2021-2026) & (K Units) Table 21. Global C1 Esterase Inhibitors Sales Volume by Type (2027-2032) & (K Units) Table 22. Global C1 Esterase Inhibitors Sales Volume Share by Type (2021-2026) Table 23. Global C1 Esterase Inhibitors Sales Volume Share by Type (2027-2032) Table 24. Global C1 Esterase Inhibitors Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global C1 Esterase Inhibitors Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global C1 Esterase Inhibitors Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global C1 Esterase Inhibitors Sales Value Share by Type (2021-2026) Table 28. Global C1 Esterase Inhibitors Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Pharmacy Table 31. Significant Companies of Other Table 32. Global C1 Esterase Inhibitors Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global C1 Esterase Inhibitors Sales Volume by Application (2021-2026) & (K Units) Table 34. Global C1 Esterase Inhibitors Sales Volume by Application (2027-2032) & (K Units) Table 35. Global C1 Esterase Inhibitors Sales Volume Share by Application (2021-2026) Table 36. Global C1 Esterase Inhibitors Sales Volume Share by Application (2027-2032) Table 37. Global C1 Esterase Inhibitors Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global C1 Esterase Inhibitors Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global C1 Esterase Inhibitors Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global C1 Esterase Inhibitors Sales Value Share by Application (2021-2026) Table 41. Global C1 Esterase Inhibitors Sales Value Share by Application (2027-2032) Table 42. Global C1 Esterase Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global C1 Esterase Inhibitors Sales by Region (2021-2026) & (K Units) Table 44. Global C1 Esterase Inhibitors Sales Market Share by Region (2021-2026) Table 45. Global C1 Esterase Inhibitors Sales by Region (2027-2032) & (K Units) Table 46. Global C1 Esterase Inhibitors Sales Market Share by Region (2027-2032) Table 47. Global C1 Esterase Inhibitors Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global C1 Esterase Inhibitors Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global C1 Esterase Inhibitors Sales Value Share by Region (2021-2026) Table 50. Global C1 Esterase Inhibitors Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global C1 Esterase Inhibitors Sales Value Share by Region (2027-2032) Table 52. Global C1 Esterase Inhibitors Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global C1 Esterase Inhibitors Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global C1 Esterase Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global C1 Esterase Inhibitors Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global C1 Esterase Inhibitors Sales by Country (2021-2026) & (K Units) Table 57. Global C1 Esterase Inhibitors Sales Market Share by Country (2021-2026) Table 58. Global C1 Esterase Inhibitors Sales by Country (2027-2032) & (K Units) Table 59. Global C1 Esterase Inhibitors Sales Market Share by Country (2027-2032) Table 60. Global C1 Esterase Inhibitors Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global C1 Esterase Inhibitors Sales Value Market Share by Country (2021-2026) Table 62. Global C1 Esterase Inhibitors Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global C1 Esterase Inhibitors Sales Value Market Share by Country (2027-2032) Table 64. Takeda Company Information Table 65. Takeda Business Overview Table 66. Takeda C1 Esterase Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Takeda C1 Esterase Inhibitors Product Portfolio Table 68. Takeda Recent Development Table 69. Pharming Healthcare Company Information Table 70. Pharming Healthcare Business Overview Table 71. Pharming Healthcare C1 Esterase Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Pharming Healthcare C1 Esterase Inhibitors Product Portfolio Table 73. Pharming Healthcare Recent Development Table 74. CSL Behring Company Information Table 75. CSL Behring Business Overview Table 76. CSL Behring C1 Esterase Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. CSL Behring C1 Esterase Inhibitors Product Portfolio Table 78. CSL Behring Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. C1 Esterase Inhibitors Distributors List Table 82. C1 Esterase Inhibitors Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. C1 Esterase Inhibitors Product Image Figure 2. Global C1 Esterase Inhibitors Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C1 Esterase Inhibitors Sales Value (2021-2032) & (US$ Million) Figure 4. Global C1 Esterase Inhibitors Sales (2021-2032) & (K Units) Figure 5. Global C1 Esterase Inhibitors Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global C1 Esterase Inhibitors Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Recombinant C1-INH Image Figure 10. Plasma-derived C1-INH Image Figure 11. Global C1 Esterase Inhibitors Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global C1 Esterase Inhibitors Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global C1 Esterase Inhibitors Sales Volume Share by Type (2021-2032) Figure 14. Global C1 Esterase Inhibitors Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global C1 Esterase Inhibitors Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global C1 Esterase Inhibitors Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Pharmacy Image Figure 19. Other Image Figure 20. Global C1 Esterase Inhibitors Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global C1 Esterase Inhibitors Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global C1 Esterase Inhibitors Sales Volume Share by Application (2021-2032) Figure 23. Global C1 Esterase Inhibitors Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global C1 Esterase Inhibitors Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global C1 Esterase Inhibitors Sales Value Share by Application (2021-2032) Figure 26. Global C1 Esterase Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global C1 Esterase Inhibitors Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global C1 Esterase Inhibitors Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global C1 Esterase Inhibitors Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America C1 Esterase Inhibitors Sales Value (2021-2032) & (US$ Million) Figure 31. North America C1 Esterase Inhibitors Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe C1 Esterase Inhibitors Sales Value (2021-2032) & (US$ Million) Figure 33. Europe C1 Esterase Inhibitors Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific C1 Esterase Inhibitors Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific C1 Esterase Inhibitors Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America C1 Esterase Inhibitors Sales Value (2021-2032) & (US$ Million) Figure 37. South America C1 Esterase Inhibitors Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa C1 Esterase Inhibitors Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa C1 Esterase Inhibitors Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. C1 Esterase Inhibitors Value Chain Figure 125. Manufacturing Cost Structure Figure 126. C1 Esterase Inhibitors Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant C1-INH
  • Plasma-derived C1-INH
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Takeda
  • Pharming Healthcare
  • CSL Behring

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global C1 Esterase Inhibitors Sales Value (2021-2032)
  4. 1.2.2 Global C1 Esterase Inhibitors Sales Volume (2021-2032)
  5. 1.2.3 Global C1 Esterase Inhibitors Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 C1 Esterase Inhibitors Market Dynamics
  1. 2.1 C1 Esterase Inhibitors Industry Trends
  2. 2.2 C1 Esterase Inhibitors Industry Drivers
  3. 2.3 C1 Esterase Inhibitors Industry Opportunities and Challenges
  4. 2.4 C1 Esterase Inhibitors Industry Restraints
3 C1 Esterase Inhibitors Market by Company
  1. 3.1 Global C1 Esterase Inhibitors Company Revenue Ranking in 2025
  2. 3.2 Global C1 Esterase Inhibitors Revenue by Company (2021-2026)
  3. 3.3 Global C1 Esterase Inhibitors Sales Volume by Company (2021-2026)
  4. 3.4 Global C1 Esterase Inhibitors Average Price by Company (2021-2026)
  5. 3.5 Global C1 Esterase Inhibitors Company Ranking (2024-2026)
  6. 3.6 Global C1 Esterase Inhibitors Company Manufacturing Base and Headquarters
  7. 3.7 Global C1 Esterase Inhibitors Company Product Type and Application
  8. 3.8 Global C1 Esterase Inhibitors Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global C1 Esterase Inhibitors Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 C1 Esterase Inhibitors Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 C1 Esterase Inhibitors Market by Type
  1. 4.1 C1 Esterase Inhibitors Type Introduction
  2. 4.1.1 Recombinant C1-INH
  3. 4.1.2 Plasma-derived C1-INH
  4. 4.2 Global C1 Esterase Inhibitors Sales Volume by Type
  5. 4.2.1 Global C1 Esterase Inhibitors Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global C1 Esterase Inhibitors Sales Volume by Type (2021-2032)
  7. 4.2.3 Global C1 Esterase Inhibitors Sales Volume Share by Type (2021-2032)
  8. 4.3 Global C1 Esterase Inhibitors Sales Value by Type
  9. 4.3.1 Global C1 Esterase Inhibitors Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global C1 Esterase Inhibitors Sales Value by Type (2021-2032)
  11. 4.3.3 Global C1 Esterase Inhibitors Sales Value Share by Type (2021-2032)
5 C1 Esterase Inhibitors Market by Application
  1. 5.1 C1 Esterase Inhibitors Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global C1 Esterase Inhibitors Sales Volume by Application
  6. 5.2.1 Global C1 Esterase Inhibitors Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global C1 Esterase Inhibitors Sales Volume by Application (2021-2032)
  8. 5.2.3 Global C1 Esterase Inhibitors Sales Volume Share by Application (2021-2032)
  9. 5.3 Global C1 Esterase Inhibitors Sales Value by Application
  10. 5.3.1 Global C1 Esterase Inhibitors Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global C1 Esterase Inhibitors Sales Value by Application (2021-2032)
  12. 5.3.3 Global C1 Esterase Inhibitors Sales Value Share by Application (2021-2032)
6 C1 Esterase Inhibitors Regional Sales and Value Analysis
  1. 6.1 Global C1 Esterase Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global C1 Esterase Inhibitors Sales by Region (2021-2032)
  3. 6.2.1 Global C1 Esterase Inhibitors Sales by Region: 2021-2026
  4. 6.2.2 Global C1 Esterase Inhibitors Sales by Region (2027-2032)
  5. 6.3 Global C1 Esterase Inhibitors Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global C1 Esterase Inhibitors Sales Value by Region (2021-2032)
  7. 6.4.1 Global C1 Esterase Inhibitors Sales Value by Region: 2021-2026
  8. 6.4.2 Global C1 Esterase Inhibitors Sales Value by Region (2027-2032)
  9. 6.5 Global C1 Esterase Inhibitors Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America C1 Esterase Inhibitors Sales Value (2021-2032)
  12. 6.6.2 North America C1 Esterase Inhibitors Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe C1 Esterase Inhibitors Sales Value (2021-2032)
  15. 6.7.2 Europe C1 Esterase Inhibitors Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific C1 Esterase Inhibitors Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific C1 Esterase Inhibitors Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America C1 Esterase Inhibitors Sales Value (2021-2032)
  21. 6.9.2 South America C1 Esterase Inhibitors Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa C1 Esterase Inhibitors Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa C1 Esterase Inhibitors Sales Value Share by Country, 2025 VS 2032
7 C1 Esterase Inhibitors Country-level Sales and Value Analysis
  1. 7.1 Global C1 Esterase Inhibitors Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global C1 Esterase Inhibitors Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global C1 Esterase Inhibitors Sales by Country (2021-2032)
  4. 7.3.1 Global C1 Esterase Inhibitors Sales by Country (2021-2026)
  5. 7.3.2 Global C1 Esterase Inhibitors Sales by Country (2027-2032)
  6. 7.4 Global C1 Esterase Inhibitors Sales Value by Country (2021-2032)
  7. 7.4.1 Global C1 Esterase Inhibitors Sales Value by Country (2021-2026)
  8. 7.4.2 Global C1 Esterase Inhibitors Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt C1 Esterase Inhibitors Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt C1 Esterase Inhibitors Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt C1 Esterase Inhibitors Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda C1 Esterase Inhibitors Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda C1 Esterase Inhibitors Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Pharming Healthcare
  8. 8.2.1 Pharming Healthcare Company Information
  9. 8.2.2 Pharming Healthcare Business Overview
  10. 8.2.3 Pharming Healthcare C1 Esterase Inhibitors Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pharming Healthcare C1 Esterase Inhibitors Product Portfolio
  12. 8.2.5 Pharming Healthcare Recent Developments
  13. 8.3 CSL Behring
  14. 8.3.1 CSL Behring Company Information
  15. 8.3.2 CSL Behring Business Overview
  16. 8.3.3 CSL Behring C1 Esterase Inhibitors Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CSL Behring C1 Esterase Inhibitors Product Portfolio
  18. 8.3.5 CSL Behring Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 C1 Esterase Inhibitors Value Chain Analysis
  2. 9.1.1 C1 Esterase Inhibitors Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 C1 Esterase Inhibitors Sales Mode & Process
  6. 9.2 C1 Esterase Inhibitors Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 C1 Esterase Inhibitors Distributors
  9. 9.2.3 C1 Esterase Inhibitors Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst